The Qatar Red Crescent Society (QRCS) is hosting its fourth Annual Scientific Conference 2026 beginning today, focusing on respiratory, allergy, and immunology diseases within primary health care. The event will run for three days and features a specialised exhibition showcasing medical and pharmaceutical companies.
The conference aims to bring together healthcare professionals and consultants from leading Qatari institutions, both in person and through virtual participation, to share expertise and enhance clinical skills in managing prevalent respiratory and immunological conditions. It is organised in strategic partnership with the Ministry of Public Health, Hamad Medical Corporation, and the Primary Health Care Corporation.
Sponsorship for the conference and the accompanying exhibition comes from several key pharmaceutical and healthcare distributors, including Hikma Pharmaceuticals, Q Life Pharma, Ali Al Suwaidi Trading, AstraZeneca Gulf, and Ion Sina.
Attendees can receive accreditation from the Ministry of Public Health’s Department of Healthcare Professions, earning 20 Category 1 Continuing Professional Development (CPD) hours, a requirement for medical license renewal in Qatar.
The scientific programme includes two simultaneous specialised workshops prior to the official opening, followed by three full days of lectures and sessions. Parallel tracks will focus on distinct professional groups such as pharmacists and physiotherapists to address their specific educational needs.
